Regulation of P2Y12 receptor expression and activity by inhibitory pathways in human platelet: a novel mode of action of antiplatelet drugs?

Mundell, Stuart J (Principal Investigator)

Status	Finished
Effective start/end date	2/07/18 → 1/02/22

1 Article (Academic Journal)

Ticagrelor inverse agonist activity at the P2Y12 receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate
Khalil, J., Dimofte, T., Roberts, T., Keith, M., Amaradasa, K., Hindle, M. S., Bancroft, S., Hutchinson, J. L., Naseem, K., Johnson, T. & Mundell, S. J., Jan 2024, In: British Journal of Pharmacology. 181, 1, p. 21-35 15 p.
Research output: Contribution to journal › Article (Academic Journal) › peer-review

Open Access
9 Citations (Scopus)